What You Need to Know
• The death toll from the Ebola outbreak in the Democratic Republic of the Congo has surpassed 1,700.
• The outbreak, caused by the Bundibugyo strain, has resulted in 3,802 confirmed cases since May 15.
• Over 17,000 contacts are being monitored, with approximately 80 percent followed up daily by health officials.
On August 4, 2026, the World Health Organization (WHO) reported that the death toll from the Ebola outbreak in the Democratic Republic of the Congo has risen to 1,707, with 3,802 confirmed cases since the outbreak was declared on May 15. The outbreak is primarily caused by the rare Bundibugyo strain of the virus and has led to the monitoring of over 17,000 contacts, with health officials successfully following up with about 80 percent daily. This epidemic is now the second-largest Ebola outbreak recorded and is progressing rapidly, with no approved vaccines or treatments available for the Bundibugyo variant. WHO officials, including Vasee Moorthy, acting head of the WHO’s R&D Blueprint programme, indicated that trials for experimental treatments and vaccines are advancing more quickly than in previous outbreaks due to years of planning.
Why It Matters
The ongoing Ebola outbreak in the Democratic Republic of the Congo highlights the challenges of managing infectious diseases, particularly those caused by rare strains like Bundibugyo. Historically, Ebola outbreaks have led to significant mortality and disruption, and this current outbreak is the second-largest on record. The rapid spread of the virus, particularly in the eastern province of Ituri, underscores the need for effective public health responses and the importance of ongoing research into treatments and vaccines. The WHO’s proactive approach in initiating clinical trials reflects lessons learned from past outbreaks, aiming to mitigate the impact of this health crisis.
Read the Full Story →
